Immunomolecular assay based on selective virion capture by spike antibody and viral nucleic acid amplification for detecting intact SARS-CoV-2 particles

BACKGROUND: Effective therapeutics and vaccines for coronavirus disease 2019 (COVID-19) are currently lacking because of the mutation and immune escape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on the propagation characteristics of SARS-CoV-2, rapid and accurate detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoli, Liu, Junye, Zhang, Hongpeng, Zhou, Hua, Wang, Wen, Ma, Yuanyan, Shen, Shimei, Cai, Xuefei, Huang, Ailong, Wang, Deqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444083/
https://www.ncbi.nlm.nih.gov/pubmed/36064407
http://dx.doi.org/10.1186/s12951-022-01558-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444083/
https://www.ncbi.nlm.nih.gov/pubmed/36064407
http://dx.doi.org/10.1186/s12951-022-01558-8

Ejemplares similares